000 04391nam a22003735i 4500
001 286090
003 MX-SnUAN
005 20160429154440.0
007 cr nn 008mamaa
008 150903s2009 xxu| o |||| 0|eng d
020 _a9781441901316
_99781441901316
024 7 _a10.1007/9781441901316
_2doi
035 _avtls000337907
039 9 _a201509030253
_bVLOAD
_c201404300337
_dVLOAD
_y201402060857
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC261-271
100 1 _aLu, Yi.
_eeditor.
_9302485
245 1 0 _aPharmaceutical Perspectives of Cancer Therapeutics /
_cedited by Yi Lu, Ram I. Mahato.
264 1 _aNew York, NY :
_bSpringer US,
_c2009.
300 _brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aTumor Microvasculature and Microenvironment: Therapeutic Targets for Inhibition of Tumor Angiogenesis and Metastasis -- Anticancer Drug Development -- Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor -- Multidrug Resistance in Solid Tumor and Its Reversal -- Targeting of Apoptosis Signaling Pathways and Their Mediators for Cancer Therapy -- Role of Telomerase in Cancer Therapeutics -- Polymeric Carriers for Anticancer Drugs -- Application of Nanobiotechnology in Cancer Therapeutics -- Receptor-Mediated Delivery of Proteins and Peptides to Tumors -- Protein Transduction Domain-Mediated Delivery of Anticancer Proteins -- Pharmaceutical Perspectives of Cancer Therapeutics: Current Therapeutic Uses of Monoclonal Antibodies -- Cancer Vaccines -- RNA Interference for Cancer Therapy -- MicroRNAs as Therapeutic Targets for Cancer -- Targeted Therapies for Malignant Brain Tumors -- The Complexity of the HIF-1-Dependent Hypoxic Response in Breast Cancer Presents Multiple Avenues for Therapeutic Intervention -- Cancer Stem Cells: Potential Mediators of Therapeutic Resistance and Novel Targets of Anti-cancer Treatments -- Image-Guided Photodynamic Cancer Therapy -- Functional Imaging of Multidrug Resistance and Its Applications -- Gene Expression Microarrays in Cancer Research -- Clinical Trials and Translational Applications in Cancer Therapy.
520 _aPharmaceutical Perspectives of Cancer Therapeutics presents a comprehensive yet easy-to-follow review of the principles, current progress and state-of-the-art of cancer therapeutics. The complexity of cancer demands an integrated understanding from both cancer biology and pharmaceutical dosage forms and drug delivery in order to warrant a successful therapeutic regimen. This book combines and merges the knowledge from these two aspects. Internationally acclaimed experts with a multi-disciplinary background, including scientists and clinicians from both academia and industries have contributed to this book to bridge the following areas between basic research and clinical application, pharmaceutical drug development processes and regulatory issues, drug design and delivery, laboratory and translational experimentation, marketing and postmarketing surveillance. Main features of the book: Anticancer drug development and regulatory processes. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways. Therapeutic approaches to employ monoclonal antibody and cancer vaccines. Introduction of new concepts such as cancer stem cells and new technologies such as nanobiotechnology, RNA interference, microRNA, and cancer cell gene profiling. Use of lipids, polymers and peptides for drug delivery and targeting to cancer cells or specific organs. Utilization of bioimaging and HIF-1 knockout animal models in cancer study. Clinical trials designs and principles
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aMahato, Ram I.
_eeditor.
_9314586
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781441901309
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4419-0131-6
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c286090
_d286090